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Oligodendrocytes in the central nervous system can be categorized as precursors, myelin-
forming, and non-myelinating perineuronal cells. The function of perineuronal oligodendrocytes 
is unknown; it was proposed that following injury, they may remyelinate denuded axons. We 
investigated these cells’ potential. A combination of cell-specific tags, microarray technology 
and bioinformatics tools to identify gene expression differences between these subpopulations 
allowed us to capture the genetic signature of perineuronal oligodendrocytes. Here we report that 
perineuronal oligodendrocytes are configured for a dual role. As cells that embrace neuronal 
somata, they integrate a repertoire of transcripts designed to create their own code for 
communicating with neurons. But they maintain a reservoir of untranslated transcripts encoding 
the major myelin proteins for – we speculate – a demyelinating episode. We posit that the 
signature molecules, PDGFR-αβ, cytokine PDGF-CC, and transcription factor Pea3, used – 
among others - to define the non-myelinating phenotype, may be critical for mounting a 
myelinating programme during demyelination. Harnessing this capability is of therapeutic value 
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Oligodendrocytes (OLGs) are morphologically and phenotypically diverse cells found in the 
central nervous system (CNS). This diversity was captured by del Rio Hortega, who in his 1928 
monograph1 described four subtypes of myelinating OLGs plus a separate class of non-
myelinating OLGs that either appose neuronal somata (perineuronal) or extend their processes to 
envelop blood vessels (perivascular). Conceivably, each of these morphological entities is 
endowed with a unique function.  Yet, OLGs are commonly defined as myelin producing cells 
with only an occasional reference to a non-myelinating OLG2,3. A detailed examination of the 
origins of OLG precursors (OLP) uncovered their complexity. Not only do spinal cord and 
hindbrain OLP originate from several dorsoventral domains that are differentially regulated by 
genes such as, e.g., nkx6.1, olig2 and sonic hedgehog (Shh) signalling4,5, but in the forebrain too, 
the generation of OLP is complex and dynamic6,7. Even the cerebral cortex may derive OLPs 
from more than one source, including an endogenous one8,9. These data stand as strong evidence 
for the diverse developmental origins of OLPs. And yet, no functional correlate to each of these 
subpopulations has been identified despite the fact that each of them has arisen from a distinct 
genetic program. Rather, the current view is that they are functionally equivalent and are 
competing for the same terrain10,11. From a simple teleological perspective, one could expect 
each class of precursor to become a distinct type of OLG within either the myelinating or non-
myelinating families. The observation that after inducing the demise of one OLP population, 
another takes its place10,11 may merely reflect the plasticity of these cells; i.e., we may conjecture 
that every OLG, independent of its assigned developmental function, might under circumstances 
of stress become a myelinating OLG.  
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To investigate the concept that a non-myelinating OLG has the capacity to transform into a 
myelinating cell, we examined its gene expression profile. We chose perineuronal OLGs (pN-
OLGs) as representatives of non-myelinating cells because they are not normally connected to 
myelin but may have the potential to remyelinate denuded axons12. We had access to a 
polyclonal antibody (OTMP) that recognizes these cells. What is known about perineuronal 
OLGs?  The morphology and ultrastructure of pN-OLGs are well defined.  The interaction of 
pN-OLGs with neuronal somata is varied and complex13,14. In the simplest case of a one to one 
association, the pN-OLG indents a neuronal soma and embraces it with its processes. The issue 
of function remains a tabula rasa. It is generally assumed that pN-OLGs express myelin genes 
and proteins, but experimental evidence is still lacking. Nevertheless, if Ludwin’s12 report were 
to be confirmed, it would indicate that pN–OLGs possess a latent myelinating machinery that 
can be activated in a regenerating environment but is blocked during development. This is 
reminiscent of satellite Schwann cells that can remyelinate but are normally suppressed from 
ensheathing a “virgin” axon15.  
If, indeed, pN-OLGs constitute a reserve pool ready to undertake repair, enhancing their 
performance could be of help in demyelinating conditions. Harnessing this potential could have 
therapeutic applications for diseases such as multiple sclerosis.  But to achieve this, we must 
have a good understanding of the genes and proteins expressed by pN-OLGs. We have 
undertaken to fill this void by examining the gene expression profile of these cells – marked by 
antibodies (Abs) A2B5+/OTMP+ - and defining their characteristics relative to the A2B5+ 
progenitor and a dedicated O4+ OLG. Herein we provide compelling evidence that pN-OLGs are 
of an OLG lineage, e.g., they transcribe genes of all the major myelin proteins but do not 
translate them. Moreover, these and other data support the notion that pN-OLGs and O4+ cells 
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are progeny of A2B5+ precursors. Despite this close lineal relationship, pN-OLGs have 
orchestrated a genetic program that sets them apart from both A2B5+ precursors and O4+ OLGs. 
Notably, we observed a high level expression of the transcription regulator, Pea3, not previously 
recognized as a player within the OLG lineage. Ordinarily, pN-OLGs communicate with 
neuronal somata by a mechanism that remains to be elucidated. However, these cells harbour the 
capability of mounting a myelinating program should circumstances require it. To the best of our 
knowledge, this is the first molecular characterization of pN-OLGs. This research should open 
up new avenues for examining the function of these cells in health and disease.  
The polyclonal antibody OTMP highlights perineuronal oligodendrocytes  
In vitro, the immuno-purified polyclonal OTMP Ab co-localizes with mAb A2B5 on the 
surface of cultured live rat OLG progenitors but does not stain mature OLGs (Fig. S1). On rat 
brain tissue, this Ab singles out pN-OLGs in their varied morphological manifestations (Fig. 1A-
C). This is not only the case for murine but also for human cells (Fig. 1D) and, presumably, other 
species (not tested). The Ab does not recognize neurons (Fig. 1 A-D), astrocytes (Fig.1E-G) or 
differentiated OLGs (Fig. 2D-F). We detected no co-localization with the Ab Iba1 on cortical 
microglial cells (not shown). Because both astrocytes and microglial cells may abut neuronal 
soma (arrowhead in Fig. 1D), although less frequently than OLGs13,14, the selective identification 
of pN-OLGs by the OTMP Ab makes it an invaluable tool for not only unambiguously 
distinguishing these cells but, more importantly, for actually defining their phenotype.   
OTMP+ perineuronal cells are of OLG lineage but do not synthesize the major myelin/OLG 
proteins 
It is generally assumed, but never proven, that pN-OLGs express myelin proteins. We tested 
this assumption by in situ double labelling these cells with OTMP and Abs that mark progenitors 
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and mature OLGs. To investigate the lineage of pN-OLGs, we labelled the cortex of a 7-day-old 
CNP/EGFP transgenic mouse with anti-GFP/OTMP.  Because EGFP is driven by the CNP 
promoter (an OLG protein), the co-localization of the Abs (Fig. 2A-C) identified pN-OLGs as 
originating from OLP. This was substantiated by the finding of transcripts for all the major 
myelin proteins in these cells (Table 1). We then asked: are these transcripts translated? Myelin 
basic protein (MBP) is the most widely used and best characterized of the OLG/myelin proteins. 
MBP was not detected immunohistochemically in pN-OLGs at P14 (Fig. 2D-F) - a time point 
when myelinating OLGs have accumulated vast amounts of this protein. This was also the case 
for other OLG/myelin proteins such as 2’, 3’-cyclic nucleotide 3’ phosphodiesterase (CNPase), 
CC1/AP7/APC, proteolipid protein, and myelin associated glycoprotein (not illustrated). 
Collectively, these outcomes portray pN-OLGs to be of a non-myelinating phenotype but with 
the ability for mounting a myelinating program. This observation has broad implications, for if 
we could exploit this capability by interfering with the molecular cues that stop pN-OLGs from 
synthesizing myelin proteins, the cells could then activate an endogenous remyelination 
programme - an issue of importance for demyelinating diseases such as multiple sclerosis.  
A2B5+/OTMP+cells are scattered throughout the developing brain 
To monitor the developmental stages of non-myelinating cells, we co-labelled acutely 
isolated P7 and P14 rat brain cells with Abs OTMP and A2B5. The rationale for a dual label 
strategy stems from the in vitro evidence that a subpopulation of progenitors has both epitopes 
(Fig. S1). Fluorescence-activated cell sorting (FACS) of this subpopulation revealed 
heterogeneity in the intensity of staining within both the single labelled as well as the double 
labelled cells (Fig. 3). Indeed, the A2B5+/OTMP+ population can be subdivided into three distinct 
subgroups that differ in the relative intensity of the two markers. Quantitatively, there were no 
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appreciable changes in the dispersion of these groups between P7 and P14. This suggests that 
differences in the stage of development are not responsible for the observed heterogeneity. 
However, because the cells were derived from whole brain preparations, variation in regional 
compartments could account for cell diversity.   
To assess this possibility, we dissected the CNS tissue into spinal cord, brain stem, basal 
ganglia, corpus callosum, and cortex at P0, P7 and P14 and repeated the experiments outlined 
above. Heterogeneity was still seen in every compartment examined (Fig. S2A-C), but there 
were interesting temporal and spatial differences in the distribution of the A2B5+/OTMP+ cells. 
Temporally, there was a significant increase in the number of these cells from a scattered few at 
P0 to a maximum at P7, when they averaged 12% of the total population. This may represent 
their steady state value as there was only a slight change by P14. The single labelled cells, A2B5+ 
or OTMP+, accounted for 16-22% of cells with only a small variation from P0 to P14. Regional 
differences were minimal in the A2B5+/OTMP+ group throughout the brain, but there was a slight 
increase in the brain stem, and a markedly low presence in the spinal cord (Fig. S2A-C). The 
single labelled cells exhibited no preferred localization within the brain or spinal cord. 
Collectively, these data show the A2B5+/OTMP+ cells to be located throughout the brain. It 
remains to be shown whether A2B5+/OTMP+ is a signature underlying a broad class of OLG 
lineage cells with the common denominator being that of belonging to the non-myelinating type 
or does it represent solely the pN-OLG?   
The A2B5+/OTMP+ cell depicts a unique oligodendrocyte lineage phenotype 
There is reliable experimental evidence that OLP originate from various sites and migrate 
throughout the CNS4-7. However, it has not been proven that they are grouped into 
subpopulations with distinct phenotypes. Functionally, there are at least three OLG subgroups: 
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precursor, myelinating and non-myelinating. Our discovery that we can place an immunological 
tag on non-myelinating cells opened up an opportunity to compare the molecular features of each 
of these OLG subpopulations. We used the Affymetrix microarray technology to identify gene 
expression patterns for cells recognized by the molecular markers A2B5+, A2B5+/OTMP+, O4+ and 
OTMP+.  We chose the P7 stage of development because it still contains progenitors while 
myelination has also begun. Hence, P7 rat brain dissociates were labelled with each of these four 
markers and were individually purified by preparative FACS. mRNA was isolated from each of 
the purified fractions and processed as described in Methods Summary and Supplementary 
Information 
We used the Principal Component Analysis on gene expression data to visualize the 
relationship between these groups (Fig. 4A). This analysis disclosed a sharp demarcation among 
the four populations.  Notably, the OTMP Ab identified a subpopulation of A2B5+ precursors 
with a distinct phenotype (Fig.4A). The transition from an A2B5+ precursor to an O4+ committed 
OLG was analyzed by Nielsen et al.16, who showed that the O4+ cell completely reorganizes its 
metabolism to assemble myelin. The OTMP+ cell is not considered here. Our interest is on the 
A2B5+/OTMP+. To bring to light the genetic signature of the A2B5+/OTMP+ phenotype, we 
analyzed its expression profile relative to gene expression patterns of each, the A2B5+ precursor 
and the O4+ committed cell, utilizing bioinformatics tools. Two general gene expression profiles 
describe the A2B5+/OTMP+ phenotype. In one, a cluster of genes exhibits higher levels of 
expression in the A2B5+/OTMP+ cell compared to both A2B5+ and O4+ cells (Fig. 4B). The other 
displays a shallow positive slope between A2B5+ and A2B5+/OTMP+ but a steep declining slope 
from A2B5+/OTMP+ to O4+  (Fig. 4C). Here we demonstrate that genes presumed to be crucial to 
the biology of the A2B5+/OTMP+ cell fall in either of these two categories. 
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A2B5+/OTMP+ cells express transcription factors judged essential for the generation of the 
OLG lineage in a context-dependent manner 
There is a vast literature documenting the critical roles of the transcription factors (TFs) 
Dlx1/2, Olig1, Olig2, Sox10 and Mash1 in the acquisition of the myelinating fate. However, 
because of the diverse origins of OLP, and because the role of each of these TFs may vary in 
each region17,18, we began by tracing the ancestry of the A2B5+/OTMP+ cell. Figure 4D (see also 
Fig. S3) shows that dlx transcripts are as high in the A2B5+/OTMP+ cell as in the A2B5 progenitor. 
Members of the dlx homeobox gene family serve as molecular markers for the progeny of 
embryonic basal forebrain multipotent stem cells capable of migrating long distances to populate 
the dorsal telencepalon and generating (in vitro) both GABAergic neurons and OLGs19. Indeed, 
dlx1/2 genes have been shown to be essential for this migration20. Similarly, OLGs and 
astrocytes emigrating from the postnatal subventricular zone to inhabit white matter and the 
cerebral cortex have been reported to be descendants of a common dlx-expressing progenitor 
originating in the embryonic ventral telencephalon7. These reports and the finding of dlx1 in 
A2B5+/OTMP+ cells (Fig. 4D) suggest that members of this population have a ventral forebrain 
ancestry.  
We next proceeded to analyze the expression of these TFs in the A2B5+/OTMP+ cell. 
Interestingly, there is little quantitative difference in the TF transcripts between the A2B5 and 
A2B5+/OTMP+ cells but there is a pronounced variance relative to the O4 cell (Fig. 4D).  
Petryniak et al.21 have recently elucidated the nature of the interactions among these TFs that 
ultimately dictate the fate of a cell to become a neuron or a myelinating OLG in the ventral 
telencephalon. For example, they report that Dlx1/2 negatively-regulate Olig2 whereas Mash1 
restricts the number of Dlx1/2+ cells, thus favouring OLGs over GABAergic neurons.  The 
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involvement of Mash1 in conjunction with Olig2 in the specification of OLGs in the developing 
ventral forebrain was also reported by Parras et al.22. In light of these findings, it is instructive to 
examine the course followed by these TFs in A2B5+/OTMP+ relative to O4+ cells. The high level 
of dlx1 transcript found in the A2B5+/OTMP+ cell (Fig. 4D) seems to fit its presumed role as an 
inhibitor of the myelinating phenotype 21. However, the expression of olig2 stays invariant in the 
three cell types (not shown). Similarly, the >5-fold higher level of mash1 transcripts in 
A2B5+/OTMP+ cells does not agree with the Petryniak et al.21 scheme. Another gene, sox9, 
required for neuron-glial switch in the spinal cord18, is >4-fold higher in the A2B5+/OTMP+ cell 
(not shown). Taken together, these results demonstrate that Dlx1, Olig2, Mash1 and Sox 9 
behave in A2B5+/OTMP+ cells in a context-dependent manner that, presumably, eventuates in 
their acquisition of a non-myelinating fate. In contrast, Olig1 and Sox10, whose transcripts are 
upregulated ~3-fold and >30-fold, respectively, in O4 cells (Fig. 4D) act according to their 
accepted role in determining the myelinating phenotype. Understanding if and how these 
transcription regulators specify the A2B5+/OTMP+ phenotype remains an exciting area for future 
research.  
The transcription factor, Pea3, is a distinguishing feature of A2B5+/OTMP+ cells  
The Pea3 group (Erm, Pea3 and Etv1) of Ets domain transcriptional regulators exhibits 
autoinhibitory activity that functions in a sumoylation-dependent fashion23.  In specific motor 
neuron pools, Pea3 controls central position and terminal arborisation – a crucial step in the 
assembly of neuronal circuits24. It was shown that the glial cell-derived neurotrophic factor 
(GDNF) from target cells induces transcription of Pea3 in neurons25. Pea3 was also reported to 
be necessary for epidermal growth factor receptor (EGFR)-stimulated expression of 
metalloproteinases 26. We observed a 52-fold increase in Pea3 transcripts in the non-myelinating 
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A2B5+/OTMP+ cell compared to the O4+ cell. This renders Pea3 as a beacon of the non-
myelinating phenotype. Interestingly, Pea3 shares this status with another family member, Erm, 
which is expressed in peripheral satellite glia but not in myelinating Schwann cells 15. The fact 
that members of the same family of TFs are used to demarcate the two phenotypes in both the 
CNS and PNS suggests that a common (or similar) mechanism underlies their segregation.  
Deciphering the function of these TFs is a goal for future research. 
Signalling pathways that may be determinants in specifying the A2B5+/OTMP+ cell 
To illuminate our understanding of the cellular processes that guide an A2B5 precursor 
towards either a non-myelinating (A2B5+/OTMP+) or a myelinating (O4) phenotype, we started 
by comparing, in pairs (i.e., A2B5+/OTMP+/A2B5 or /O4), the expression profiles of molecules 
known to play critical roles in patterning the CNS.  Sonic hedgehog (Shh) and Wingless (Wnt) 
fall into this category. In addition to their cognate receptors, Patched and Smoothened (for Shh) 
and Frizzled (for Wnt), they require at least one essential co-receptor – LRP – a member of the 
low density lipoprotein receptor-related family and heparan sulfate proteoglycans (HSPGs) for 
transport and signal transduction. There is a large body of experimental evidence demonstrating 
the vital importance of these signalling molecules in specifying oligodendrogenesis27-31,10, but the 
full range of their action has yet to be unravelled. However, the core molecular players have been 
identified. We used this knowledge to assess whether these morphogens have any part in 
specifying the A2B5+/OTMP+ cell. We found a >7- and >9-fold augmentation, respectively, of 
the Smoothened (Smo) and Gli transcripts in the A2B5+/OTMP+ cells compared to A2B5+ and O4+  
cells.  Such a metabolic investment by this cell indicates that it has access to a source of Shh, and 
that there is a functional objective to be attained.   
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Shh is required for the expression of PDGFR-α27, considered to be one of the earliest markers 
for OLPs. Significantly, at a time when PDGFR-α is no longer detected in the O4+ cell, we find a 
7.2-fold upregulation of its transcripts in the A2B5+/OTMP+ cell. Data analysis suggests that Shh 
has a part in this event (Fig. S4). Of biological relevance is our observation that A2B5+/OTMP+ 
cells incorporate this receptor in a context-specific role. In addition to pdgf-α, the cells transcribe 
pdgfR-β and the cytokine pdgf-c – a high-affinity ligand for PDGFR-αβ and a strong mitogen32. 
The network in Fig.5A depicts predicted interactions among these and other molecules based on 
well-characterized systems. We posit that the binding of secreted PDGF-CC to the α- and β-
PDGF receptor effects their association into the PDGFR-αβ heterodimer, thus silencing the 
response of A2B5+/OTMP+ cells to PDGF-AA - a ligand for the myelinating phenotype. Tacitly, 
this event specifies the A2B5+/OTMP+ fate. The usage of the cytokine PDGF-CC creates an 
autocrine loop that serves not only to control receptor activity but also cell numbers. Although 
the molecular mechanism underlying these interactions remains to be solved, the interactions per 
se can be viewed as a step toward establishing the A2B5+/OTMP+ phenotype.     
  Turning to Wnt, it is perhaps one of the most versatile morphogens, regulating as it does 
gene expression, cell fate, cell adhesion, and cell polarity. All the three vertebrate Wnt pathways 
use the frizzled (Fzd) receptor but the adaptor proteins vary33,34. The Wnt/β-catenin pathway 
directs the sequential onset of neurogenesis and gliogenesis30 and prevents the differentiation of 
OLP31.  To appreciate how critical Wnt signalling must be to the biology of A2B5+/OTMP+ cells, 
it suffices to note that the Fzd2 transcript is 14-fold higher in A2B5+/OTMP+ cells than in O4+ 
cells. To derive a cell-specific role for Wnt signalling, we analyzed the gene profile using 
interactive networks. Setting aside the well-known gene repertoire controlled by Wnt - all of 
which are highly expressed by the A2B5+/OTMP+ cells (Fig. 5B) - one protein, Nr-CAM, appears 
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as a likely downstream target of Wnt signalling because of the known LEF1 binding to Nr-CAM 
promoter35. Nr-CAM is a transmembrane adhesion molecule of the Ig superfamily. It is found in 
neurons and Schwann cells, but not in OLGs. Nr-CAM is critical in the early events of node of 
Ranvier formation in the PNS36. There is an 11-fold upregulation of the nr-cam transcript in 
A2B5+/OTMP+ cells. We postulate that Nr-CAM might serve as a point of contact with a neuron 
in a direct cell to cell contact as exemplified in Fig. 1A as well as through cellular processes as 
are seen in Fig. 1B. Other molecules may then modulate and strengthen these interactions.  
As illustrated in Fig. 1, the pN-OLG either abuts a neuronal soma or contacts it through its 
processes. Hence, it was relevant to investigate signalling pathways that are transduced by direct 
cell to cell contact. The Notch and the Eph/ephrin pair act in this manner. In the fly, Notch 
inhibits differentiation by lateral signalling and controls cell fate by inductive interactions 37. In 
vertebrates, it may additionally diversify progenitor populations 38. The network shown in Fig. 
5C brings to light three aspects of Notch signalling in A2B5+/OTMP+ cells. First, we noticed a 
transcriptional activation (>5-fold) of the bHLH TF ASCL1/Mash1 (Fig. 5C). During 
neurogenesis, there is a tight cross-regulation between Notch and the two TFs, Mash1 and 
Dlx1/2, that eventuates in sequential specification of progenitors39. Whether or how these factors 
specify the A2B5+/OTMP+ cell is still an open question. Nonetheless, our results support the idea 
that in A2B5+/OTMP+ cells, these two TFs together with Olig2 engage in a context-specific 
interplay that differs from their behaviour in, e.g., OLGs (Fig. 4D). Second, we observed the 
(>13-fold) upregulation of hes5 (Fig. 5C), a Notch target and an inhibitor of myelin gene 
expression40. Finally, Fig. 5C implicates Notch1 in the elevated transcription in A2B5+/OTMP+ 
cells of lipocalin-prostaglandin D2 synthase (L-PGDS), also known as β-Trace. This is puzzling 
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for Notch1 has been shown to decrease PGDS expression, but the A2B5+/OTMP+ cells reveal 
elevated levels of both Notch1 and PGDS.    
The Eph receptors and the ephrins are transmembrane tyrosine kinases. Their binding and 
subsequent clustering transduce bidirectional signals that regulate cell migration, adhesion or 
repulsion. This interaction requires direct cell to cell contact. A large number of other proteins 
modulate the outcome41-43. We have utilized an Eph/ephrin canonical pathway to assess the 
expression of these tyrosine kinase receptors in the A2B5+/OTMP+ cells. Significantly, we noted 
a selected transcription of the ephA2,4,5 class of receptors and class b3 ephrins in the 
A2B5+/OTMP+ pathway (Fig. 5D). Since their interaction is mostly between members of the 
same class, this allows the A2B5+/OTMP+ cells to be receivers of either forward or reverse 
signalling. That the latter may be of physiological significance for these cells can be surmised 
from both the expression of the G-coupled CXCR4 receptor and its ligand SDF-1 (Fig. 5D) and 
from evidence of their participation together with ephrin-B in controlling migration in other cell 
types (e.g., granule cells)44,45. One attractive feature of the Eph/ephrin signalling is that it fosters 
cell to cell attachment and detachment. The action is not strictly reversible as cell separation 
requires endocytosis or proteolysis. Nevertheless, it does provide flexibility for cells to engage or 
disengage when circumstances demand it. As argued below, we speculate that pN-OLGs may 
avail themselves of this prerogative in specific circumstances.  
The A2B5+/OTMP+ cell amasses a complex extracellular matrix 
The A2B5+/OTMP+ gene profile presented here is cell-specific (i.e., it contains only those 
transcripts that differ from A2B5 or O4). Therefore, assessment of its contribution to the ECM 
may assist in identifying events that control the casting of the non-myelinating phenotype.   
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Examination of the A2B5+/OTMP+ transcripts revealed an unusual richness of adhesion 
molecules, receptors, and ECM molecules. Their levels of expression range from >3 to >7 
compared to either A2B5+ or O4+. It is reasonable to assume that such a metabolic investment 
signifies that the corresponding proteins are synthesized. To gain a glimpse of the context in 
which these proteins are utilized and their regulation, we examined them as part of interacting 
networks (Figs. 6A-D). Fig. 6A predicts the extracellular accumulation of collagens, including 
the unusual Col18A1 - a HSPG - nidogen, and reelin. In Fig.6B there is a display of members of 
the bone morphogenetic protein (BMP) family, their receptors, the inhibitor noggin and the 
receptor endoglin. There is an indication that the secretion of collagens and BMPs as well as 
activation of the BMPR1/2 may be controlled by members of the TGFβ/BMP receptor/ligand 
family because of the downregulation of the transcription regulator SMAD7 - an inhibitor of 
TGFβ/activin and BMP signalling46. It is the interplay and fine tuning of these molecules 
together with other morphogens that, ultimately, demarcate cell fate39,47. 
Fig. 6C exhibits a display of metalloproteases (MMPs), their inhibitors and the chondroitin 
sulfate proteoglycan (CSPG), versican, mostly orchestrated by the Erb-B2 tyrosine kinase, in 
part for its own usage as it needs MMPs for signalling48. But Fig. 6C also indicates an interface 
with other signalling pathways, e.g., Shh, as its co-receptor LRP1 appears to be interacting with 
several components. The complex cross-talk between the ECM and the cell can be further 
appreciated in Fig. 6D, where we see apolipoprotein E and α2-macroglobulin, both secreted by 
the A2B5+/OTMP+ cell, as having a direct impact on LRP1. Another highly expressed (> 7-fold) 
secretory product, spondin, modulates Wnt by inhibiting its co-receptor, LRP5/649.   
Discussion  
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In this work we sought to obtain the genetic signature of pN-OLGs by tabulating only those 
genes that differed significantly (> 2-fold) from either the A2B5+ OLP or the O4+ OLG. The 
outcome revealed an OLG lineage cell with a novel phenotype (Figs. 4B-D). By adopting the 
PDGFR-αβ and its high affinity ligand, PDGF-CC (Fig. 5A), the A2B5+/OTMP+ cell has 
effectively demarcated a boundary between itself and the other members of its lineage. But the 
most notorious feature of this phenotype is that it has amalgamated genes pertaining to Schwann 
cell lineages. To begin with, the usage of the Ets domain transcription regulator, Pea3, 
presumably to establish and/or control the phenotype per se, mimics satellite Schwann cells 15. 
Likewise, the secretion of fibrous collagens, nidogen (Fig. 6A) and the high level expression of 
NrCAM (Fig. 5B), and α7β1 integrin (not shown) by A2B5+/OTMP+ cells are atypical for OLG 
lineages but are part of the Schwann cell repertoire. Notwithstanding these similarities, pN-
OLGs and satellite Schwann cells function in a distinctive fashion50. We interpret these results as 
indicating that pN-OLGs have developed a code for communicating with neurons that differs 
significantly from the one used by myelinating OLGs. This finding brings to the fore an 
intriguing possibility. It is well known that the interaction between a myelinating OLG and an 
axon varies from a one to one relationship - not unlike that of the Schwann cell - to one plus 
many axons51. Could different codes be used for each case?  Deciphering the way in which the 
structure of the pN-OLG ECM and plasmalemma influence cell to cell interaction should 
illuminate the broader issue of OLG-neuron interaction.  
Our finding that pN-OLGs belong to the OLG lineage raises the question of lineage 
progression. This is particularly so because the embryonic and early postnatal A2B5+ cell  is 
highly heterogeneous (Fig. 3) and generates a varied progeny52,53. The work here pertains to a P7 
A2B5+ cell acutely isolated from a whole brain dissociate. We have demonstrated that the A2B5+ 
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cell, long-accepted as an OLG progenitor and shown to be a necessary intermediate in the path 
towards a myelinating phenotype54, can also take a different route and become an A2B5+/OTMP+ 
cell, i.e., non-myelinating (Fig. 4A). Given that an A2B5+ cell is the founder of both phenotypes, 
the challenge remains to discover at what stage of development they emerge. Is lineage 
progression linear or branched? And, more importantly, who triggers the signal? Is it cell-
autonomous or does it depend on an extracellular induction? In this context, our discovery that 
A2B5+/OTMP+ cells express high levels of the TF Pea3 together with the suggestion that Erm - a 
member of the Pea3 group - is involved in driving Schwann cell precursors toward a satellite 
phenotype15 makes Pea3 a bona fide contender for a role in creating/maintaining the 
A2B5+/OTMP+ non-myelinating phenotype. The lineage progression from peripheral ganglia 
precursors to Schwann cells has been postulated to involve an Erm+ cell intermediate15. Could 
this also be the case for OLGs? The data herein set the stage to search for the answer. 
A long-standing issue has been defining the function of pN-OLGs. It has been reported that, 
after injury, pN-OLGs protect themselves and neurons from apoptosis by upregulating L-PGDS 
55. But here we have identified a physiological high level of L-PGDS (Inset Fig. 5C). The 
question is, to what end?  L-PGDS has a restricted distribution and a dual function56. As an 
enzyme, it catalyzes the conversion of prostaglandin H2 to D2; but as a lipocalin, it is a 
transporter of hydrophobic molecules. In brain cell lines, L-PDGS is activated by protein kinase 
C through a mechanism of de-repression of Notch-Hes signalling 57. While not denying that L-
PGDS may be important to the physiology of the pN-OLGs, more research is required to define 
its impact on pN-OLG function. The work by Yamazaki et al.58 showing a bidirectional 
interaction between perineuronal astrocytes and neurons in the CA1 region of the rat 
hippocampus raises the intriguing possibility that pN-OLGs may engage in a related activity. 
 17
Indeed, synaptic signalling between GABAergic interneurons and OLP has been reported by Lin 
and Bergles59. However, their description of the cell as having a round soma with no visible 
processes does not correspond to the morphology of pN-OLGs. Nonetheless, it is of interest that 
pN-OLGs express GABA receptors (Fig. 5B). Undoubtedly, this is a research venue worth 
pursuing. 
It has been proposed that pN-OLGs can partake in remyelination60. Our results indicate that 
they have the molecular armamentarium to respond to a demyelinating eventuality. They retain 
the capacity for migration and proliferation; they have receptors, signalling and ECM molecules 
they would need but, most importantly, they carry transcripts for all the major myelin proteins 
(Table 1). Furthermore, there is a 32-fold upregulation of the EGFR in pN-OLGs vs O4 OLGs. 
This is striking in view of the report by Aguirre et al.61 that the EGFR regulates 
oligodendrogenesis and remyelination.  While this receptor must be physiologically engaged in 
functions other than remyelination, its high presence, per se, is an assurance that it can play its 
part when called upon.   
One could envision a scenario where, in response to a demyelinating insult, the cell would 
use the Eph/ephrin bonds to detach from the neuron. The cytokine PDGF-CC - sequestered in the 
ECM in its latent form – would be exposed to proteolytic enzymes (accompanying trauma), 
thereby liberating its growth factor domain for interaction with the PDGFR-αβ; proliferation 
would then ensue in an asymmetric fashion. One daughter cell would rejoin the neuron; the other 
would activate its myelinating program to repair the damage. The description herein of the 
genetic signature of pN-OLGs should open up vistas for testing these hypotheses and, thereby, 
advance our knowledge of the biology and function of these cells.   
METHODS SUMMARY 
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Immunohistochemistry of rodent and human brain. Animals were handled according to NIH 
guidelines. C57BL/6 mice or Sprague Dawley rats (Taconic Farms, Germantown, NY) were 
anesthetized by intraperitoneal injection of Xylazine plus Ketamine and perfused through the 
heart with PBS followed by 4% paraformaldehyde in PBS. The brains were removed and 
sectioned with a vibratome into 15-20 μm sections. Staining was done on free-floating sections. 
Experimental details of staining and analysis can be found in Supplementary Information. 
Human tissue. Primary motor cortex samples originated from individuals whose autopsies 
revealed no central nervous system disorder. The tissue was supplied by the Department of 
Forensic Medicine, Semmelweis University Medical School and handled in Budapest (Hungary), 
an activity reviewed by the Office of Human Subjects Research, NIH (OHSR #2481). Processing 
is described in  Supplementary Information.  
Cell preparation and sorting. Cell preparation and isolation was performed as previously 
described16. 
Fluorescence-Labeled Cell Sorting (FACS) of Rat Oligodendrocytes. Whole brains were 
dissected from P7 and P14 rats, and the cerebellum and meninges were removed. The brains 
were kept in 4˚C wash buffer (Hanks buffer pH 7.4, 20mM Hepes, 50μg/ml gentamicin, and 
0.1% bovine serum albumin). Labeled cell suspensions were prepared with papain digestion and 
analyzed using a FACSTAR+ flow cytometer (Becton Dickinson, Mountain View, CA). Three 
independent experiments were performed on P7 animals and 2 independent experiments on P14 
animals. Experimental details are given in Supplementary Information.  
Microarray. Total RNA was extracted using the RNeasy micro kit (Qiagen. Valencia, CA). The 
quality of total RNA was assessed using Agilent’s Bioanalyzer microchip (Palo Alto, CA). 100 
ng of total RNA was amplified following Affymetrix’s small sample labeling protocol (vII). The 
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protocol contains two rounds of reverse transcription and in vitro transcription with the biotin 
label being incorporated during the second round of in vitro transcription. The raw data will be 
deposited in the Gene Expression Omnibus accessible at http://www.ncbi.nlm.nih.gov/geo/ 
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Figure 1. The polyclonal antibody OTMP recognizes perineuronal oligodendrocytes in 
cortical gray matter but does not stain neurons or astrocytes. Rat (A-C) and human (D) brain 
sections were labelled for OTMP (red-A,B; green-C), NeuN (green-A,B; red-C), and DAPI 
(blue) for confocal (A-C) or epifluorescence (D) microscopy. Notice that OLGs actually indent 
the neuronal soma (arrows in A and D) and their processes envelop the neuron (arrowheads in 
B). Arrowhead in D points to a nucleus abutting a neuron that is not stained by OTMP (astrocyte 
or microglial cell?). There is no overlap between OTMP and NeuN, i.e., OTMP does not stain 
neurons. E-G presents sections of a rat corpus callosum double stained with GFAP (E, green) 
and OTMP (F, red). Merge in G shows no co-localization with GFAP. Scale bar = 10 μm  
 
Figure 2.  OTMP+ perineuronal cells are of OLG lineage but do not synthesize myelin 
proteins. Arrows in A-C point to a perineuronal cell in the cortex of a 7-day-old CNP/EGFP 
transgenic mouse double stained with anti-GFP (A, green) and OTMP (B, red). The overlap of 
the two (C) demonstrates that pN-OLGs are OLG precursor’s progeny. Arrows in D-F direct to a 
pN-OLG from a P14 rat cortex double labelled for OTMP (D, green) and MBP (E, red). Note the 
absence of MBP (E) in the perineuronal cell and the strong presence of MBP in the myelinated 
fibers (arrowheads in E and F). Panel F (merge) confirms that pN-OLGs do not synthesize MBP.  
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Figure 3. A2B5+/OTMP+cells are scattered throughout the developing brain. Panels A (P7) 
and B (P14) illustrate a representative fluorescence-activated cell sorting experiment, which 
addresses the distribution of acutely isolated OLG progenitors double labelled with A2B5 and 
OTMP. Each graph is divided into upper left (UL), upper right (UR), lower left (LL), and lower 
right (LR) quadrants, depicting OTMP-/A2B5+, OTMP+/A2B5+, OTMP-/A2B5− and OTMP+/A2B5− 
cell phenotypes, respectively. The percentage of cells found in the individual quadrants is 
indicated as the percent gated. There is heterogeneity in the intensity of staining within both the 
single and the double labelled cells. Quantitatively there are no appreciable changes in cell 
dispersion between P7 and P14.  
Figure 4. The A2B5+/OTMP+ cell depicts a unique oligodendrocyte lineage phenotype. We 
used Affymetrix microarray technology to identify gene expression patterns for P7 cells 
recognized by four molecular markers A2B5+, A2B5+/OTMP+, O4+ and OTMP+.  The Principal 
Component Analysis (A) disclosed a sharp demarcation among the different populations. 
Noteworthy, is the observation that the OTMP antibody identifies a subpopulation of A2B5+ 
precursors with a different phenotype. B and C illustrate two general gene expression patterns of 
the A2B5+/OTMP+ phenotype compared to both A2B5+ and O4+ cells. In D the expression patterns 
of transcription factors demonstrated to be critical for the development of OLGs are compared 
for the three subpopulations.  
Figure 5. Signalling pathways and molecules important to the A2B5+/OTMP+ phenotype. 
We have used the Ingenuity software to analyze A2B5+/OTMP+gene expression data either as 
interacting networks or as canonical pathways. Red denotes upregulation and green 
downregulation of transcripts in the A2B5+/OTMP+ relative to A2B5+ precursor (F) or the O4+ 
committed OLG (A-E). Edge types: solid line = direct action; broken line = indirect action; 
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arrow from A to B = act on; line joining A to B = binding only; line ending in vertical 
dash=inhibits. A. This network illustrates upregulation of transcripts for pdgfr-α (arrowhead), 
pdgfr-β (arrowhead), and cytokine pdgf-c (asterisk). Their interaction should eventuate in the 
expression of the heterodimer PDGFR-αβ on the surface of the A2B5+/OTMP+ cell, silencing its 
response to PDGF-AA – a ligand for the myelinating OLG, and thereby, segregating the two cell 
types. Note also the downregulation of pdgf-a (double arrow). That sonic hedgehog (Shh) has a 
role in the increased (7.2-fold) transcription of pdgfr- α can be surmised from Fig. S4. The 
growth factor receptor (double asterisks) implicated in the regulation of the other components 
remains to be elucidated. A cross-talk with Notch signalling (>4-fold increase in Hey1; large 
arrow) is hinted by its apparent involvement in the increased expression (3.3-fold) of 
phospholipase C-γ (small arrow). B. A2B5+/OTMP+ transcripts pertaining to Wnt signalling are 
shown in an interacting network. Asterisks mark the receptors Fzd, co-receptor LRP6, and the 
protein DVL1 (dishevilled); they are all upregulated. Notice that NrCAM (arrowhead) appears as 
a cell specific target of Wnt signalling. C. This network illustrates three aspects of Notch 
signalling (asterisk):1. (large arrow) upregulation of ASCL1/Mash1; 2. (arrowhead) increased 
expression (>13-fold) of Hes5; 3. (small arrow) enhanced transcription of lipocalin-prostaglandin 
D2 synthase (L-PGDS). Inset shows an OTMP+/L-PGDS+ pN-OLG demonstrating that the L-
PGDS protein is expressed. D. A2B5+/OTMP+ transcripts were analyzed using the canonical 
pathway for the Eph/ephrin tyrosine kinases. Small arrows point to the upregulated EphA 
receptors. Arrowhead signals the ephrin B receptor. Asterisks denote the G-coupled CXCR4 
receptor and its ligand SDF-1, which together with ephrin B may play a role in cell migration. 
Figure 6. The ECM matrix of A2B5+/OTMP+ cells (see Fig. 5 for a description of the method 
of analysis and the meaning of symbols). A. Asterisks point to the different collagens that are 
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secreted by the A2B5+/OTMP+ cells. Small and large arrow, respectively, indicate reelin and 
nidogen.  Note that SMAD7 (double arrows) may regulate the secretion of some of the collagens. 
B. Asterisks mark secreted BMPs; arrowheads point to their receptors; arrow indicates the 
receptor endoglin. Note the role of SMAD7 (double arrows). C. This network illustrates the role 
of the kinase ERB-b2 (double arrow) in the shaping of the ECM of the A2B5+/OTMP+cells. 
Asterisks point to MMPs; arrowhead signals their inhibitor, TMP; small arrow indicates the 
chondroitin sulphate proteoglycan, versican. D. This network demonstrates the cross-talk 
between the ECM and the cell (see text). 
Supplementary Information 
Methods 
Immune-purified polyclonal antibody, OTMP.  A 20 amino acid peptide of sheep OTMP 
(residues 254-273) was synthesized, coupled to a carrier and injected into two rabbits 
(Biosource, Inc. Camarillo, CA).  Following testing by ELISA and immunohistochemistry, the 
most active batch of serum was purified on a peptide-affinity column. 
Immunohistochemistry of rodent and human brain. Free-floating sections were blocked with 
3% normal goat serum (NGS) in PBS containing 0.1% Triton X-100 for 1½ h at room 
temperature. Primary antibodies (Abs) were applied overnight at 4ºC. Affinity purified 
polyclonal rabbit anti-OTMP (1:200) was used in combination with Abs for the identification of: 
1) neurons (anti-NeuN, 1:500; Chemicon, Temacula, CA); 2) oligodendrocytes-CC1/Ab7/APC, 
1:350, Oncogene Research Products, Boston, MA), anti-CNPase (1:500, Sternberger 
Monoclonals, Lutherville, MD), anti-MBP, (1:1000, Covance); 3) microglial cells, (anti-Iba1, 
Wako Chemicals, Richmond, VA); 4) astrocytes (anti-GFAP, 1:1,000, Sigma, St. Louis, MO). 
After three washes with PBS, sections were incubated for 1½ h with anti-rabbit IgG labeled with 
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Alexa Fluor 594 (1:800) and anti-mouse IgG labeled with Alexa Fluor 488 (1:800) (Molecular 
Probes, Eugene, OR). The sections were washed with PBS, mounted onto slides and covered 
using Vectashield with DAPI. Two types of controls were included: 1) primary Ab was replaced 
by pre-immune serum; 2) primary Ab was omitted. Images were captured with an Olympus 
fluorescent microscope fitted with a Cool Snap digital camera (Photometrics, Tucson, AZ).  
Confocal images were taken with a Zeiss LSM 410 laser scanner microscope with a 25X Plan 
Neofluor Objective and a 2X or 3X Zoom. The excitation wavelengths used were: 413 nm for 
DAPI, 488 nm for green and 543 nm for red fluorescence.  
Human tissue. The dissected tissue blocks were fixed in 4% paraformaldehyde for 2 weeks. 
Free-floating brain sections (15 μm) obtained with a vibratome (Leica WT1000S) were treated 
with 10% NGS for 1h to reduce non-specific binding followed by incubation for 48 hr at 10˚C 
with primary Abs diluted in PBS containing 1% NGS: OTMP (1:300), NeuN (1:600), CC1 
(1:400). Immunoreactivity was visualized with species-specific secondary Abs (1:300) 
conjugated to either Alexa Fluor 488 or Alexa Fluor 594. The free-floating sections were 
mounted onto glass slides and coverslipped with Vectashield mounting medium containing 
DAPI. Signal was visualized using an inverted epifluorescence microscope (Olympus BX51). 
Images were acquired using a cooled digital camera controlled by Analysis Lab Digital imaging 
software. The contrast and brightness of the digitally acquired images were adjusted with Adobe 
Photoshop 5.5. 
Cell preparation and sorting. We followed the protocol described by Nielsen, et al.16 Briefly, 
whole brains were dissected from postnatal day 7 Sprague-Dawley rats, and the cerebellum and 
meninges were removed in 4˚C Hank’s Balanced Salt Solution. Brains were dissociated using 
gentle trituration, followed by a 10 min papain and a 10 min DNase I digestion. A 15%-40% 
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Percoll gradient was used to purify cells away from myelin debri. The OTMP Ab was used in 
combination with the IgM mAb A2B5 (Eisenbarth et al., 1979), and the IgM mAb O4 (Sommer 
and Schachner, 1981; Gard and Pfeiffer, 1990). The latter two Abs were produced and purified 
from hybridoma cultures grown in house. The O4 labeling was detected using goat anti-mouse 
IgM conjugated with Alexa Fluor 488. Normal mouse IgM was used to block excess IgM 
binding sites before detection of A2B5. A2B5 was custom-conjugated with biotin using a standard 
biotinylation kit (Pierce, Rockford, IL), according to manufacturer’s specifications, and 
visualized with streptavidin conjugated with phycoerythrin (PE) and Texas red (TxR) tandem 
dye (Caltag). OTMP was detected with anti-rabbit IgG conjugated to PE.  Labeled cell 
suspensions were physically sorted directly into collection tubes containing RNAlater (Ambion, 
Austin, TX) using a FACSVantageSE flow cytometer (Becton Dickinson, Franklin Lakes, NJ). 
FITC, PE, PE-TxR, and PE-Cy5 were excited by an argon laser (model 2016, Spectra Physics, Mountain 
View, CA) and the resulting emission was collected with bandpass filters at 530±30nm, 575±25nm, 
615±10nm, and 670±20nm. Cell Quest Acquisition and analysis software was used to quantify 
fluorescence signal intensities and cell numbers in each cell population. 
Microarray. 10 μg of biotin-labeled and fragmented cRNA was hybridized to Affymetrix Rat 
expression 230 microarrays (Affymetrix, Santa Clara, CA).  The microarrays were hybridized, 
washed and scanned according to Affymetrix standard protocols. Genespring analysis software 
was used for RMA pre-processing of the raw CEL files and for normalization. The data were 
normalized using a per chip normalization (normalized to the 50th percentile) and per gene 
normalization (normalized to the median).  A 2-fold difference in normalized expression value 
was used to identify differentially regulated transcripts.  In addition, a Welch t-test was 
performed without an assumption of equal variances.  The Benjamini and Hochberg multiple 
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testing correction was used with a false discovery rate of 0.05.  The two-fold cutoff and the 
statistical test were used to obtain the differentially regulated gene lists.  
Immunocytochemistry of cutured live rat oligodendrocytes. A2B5+ oligodendrocyte 
progenitors (OLP) FACS purified were maintained as such by supplementing the medium with 
growth factors by way of a conditioned medium from a neuroblastoma (B104) cell line. The cells 
switch to an OLG phenotype (differentiate) following removal of the conditioned medium. The 
two phenotypes have characteristic morphologies and express different surface markers. The 
progenitor is mostly bipolar and is marked by the mAb A2B5, whereas the young OLG is mainly 
multipolar and is stained by the mAb O4.  
We double stained live cells with either A2B5/OTMP or O4/OTMP. For this we used the regular 
medium containing either mAb A2B5 or mAbO4 (1:500) and polyclonal anti-OTMP (1:100) and 
cells were placed back in the incubator for 30 min. Medium was then removed and cultures were 
washed twice with PBS (Ca2+Mg2), fixed with 4% paraformaldehyde in PBS (Ca2 + Mg2) for 10 
min, and washed with PBS 3 times for 10 min each. The secondary Abs, goat α-mouse IgM 
(A2B5 or O4) Alexa-Fluor 488 (green)/goat α-rabbit IgG (OTMP) Alexa-Fluor 594 (red) at 1:700 
in PBS containing 3% normal goat serum (NGS; Gibco, Long Island. NY) were applied for 2hr 
before slides were washed once for 15 min and 4 times for 5 min, then mounted with Vectashield 
containing diamidino 2-phenylindol-HCl (DAPI) (Vector Laboratory, Burlingham, CA). 
Supplementary Figure Legends 
Figure S1. The antibody OTMP stains live rat oligodendrocyte progenitors. Staining of live 
rat OLGs with A2B5 (green) or O4 (green) and OTMP (red). A-C: progenitors, notice co-
localization A2B5 and OTMP (B). D-F: differentiated OLGs, no co-localization of O4 and OTMP 
in the fully differentiated cell (C). 
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Figure S2. Developmental distribution of A2B5+/OTMP+ cells in different brain 
compartments. CNS tissue was fractionated into spinal cord, brain stem, basal ganglia, corpus 
callosum, and cortex at P0, P7 and P14. Acutely isolated cells were double labelled with mAb 
A2B5 and OTMP and fractionated by fluorescence-activated cell sorting. Each graph is divided 
into upper left (UL), upper right (UR), lower left (LL), and lower right (LR) quadrants, depicting 
OTMP-/A2B5+, OTMP+/A2B5+, OTMP-/A2B5− and OTMP+/A2B5− cell phenotypes, respectively. 
The percentage of cells found in the individual quadrants is indicated as the percent gated. A. P0; 
B. P7; C. P14. (See text for results.)  
Figure S3. Expression of dlx1 and pax6 in A2B5+/OTMP+ cells.  Arrowheads point to the 
upregulation of dlx1 and pax6; asterisks signal the downregulation of sox2 and nkx2.2. Note that 
these events appear to be interrelated.                                                                                                                       
Figure S4. Participation of sonic hedhehog (Shh) in the fate of A2B5+/OTMP+ cells.  The 
network shows the upregulation of Shh receptors, Patched and Smoothened (arrowheads) and the 
transcription regulators Gli1-3 (asterisk). There is an indication that Shh plays a role in the 
increased expression of PDGFR-α.   
 
 










